Increased total tau (t-tau) in cerebrospinal fluid (CSF) is a key characteristic of Alzheimer’s disease (AD) and is considered to result from neurodegeneration. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.